Tobacco Use Disorder (TUD)
Ben Johnson
Background
- All patients should be screened for nicotine use (smoking, chewing, and vaping of nicotine containing products)
- Nicotine withdrawal is one of the most common reasons that patients leave the hospital before medically advised
- Hospitalized patients receiving pharmacotherapy for nicotine use have higher rates of cessation
Management
- Combination therapy is superior to single therapy alone
- Basal:
- Transdermal nicotine patch provides sustained levels of nicotine
- > 10 cigarettes (1/2 pack) per day: 21 mg patch
- < 10 cigarettes (1/2 pack) per day: 14 mg patch
- Remove overnight, abnormal dreams and nightmares are a common if not removed
- Bolus
- Gum/ Lozenge provides immediate nicotine for breakthrough cravings
- First cigarette within 30 minutes of waking: 4 mg gum/lozenge
- First cigarette after 30 minutes of waking: 2 mg gum/lozenge
- Patients smoking 1+ packs per day will likely still require 4 mg gum/lozenge
- Order q1h prn as patients will titrate utilization as they would with their outpatient nicotine use
- Chew and park method for nicotine gum; sublingual absorption needed to bypass first metabolism
- Other medications
- Varenicline
- Equivalent efficacy to combination NRT for smoking cessation
- Limited utility in the inpatient setting due to side effect tolerability and need for dose titration over multiple days
- Bupropion
- Effective but less efficacious than combination NRT and varenicline
- Limited utility in the inpatient setting due to dose titration over a week and delay in steady state blood levels
- Contraindicated in those with seizure disorder and those at risk of seizures